Neonatal sepsis is a life-threatening response to bloodstream infections that occur in newborns fewer than 28 days old. Due to their immature immune systems, newborns are particularly susceptible to infections. The BARNARDS study estimated that 2.5 million neonates or infants in the first month of life die annually of sepsis, with the greatest burden in low- and middle-income countries. Since neonatal sepsis progresses rapidly, it requires immediate treatment with IV fluids and antibiotics. The risk of death from neonatal sepsis increases 7.6% every hour a treatment is delayed.
Current Development Stage: Feasibility
CARB-X Investment: US$3.5M
Initial CARB-X Investment Date: January 14, 2025
Current Development Stage: Feasibility
CARB-X Investment: US$3.5M
Initial CARB-X Investment Date: January 14, 2025
Location: United States, California, Santa Clara
Investors 1
| Date | Name | Website |
| 01.03.2025 | CARB-X | carb-x.org |
Mentions in press and media 1
| Date | Title | Description |
| 06.09.2023 | TechCrunch Disrupt 2023 Startup Battlefield 200: Health tech and sustainability | You’re just a couple weeks away from meeting the Startup Battlefield 200 companies in person at TechCrunch Disrupt 2023! We’re incredibly proud of — and impressed by — this year’s hand-picked cohort. To avoid utter overwhelm, we’re announci... |